Editorial Comment: A Cautionary Experience With Drug-Eluting Bead Transarterial Chemoembolization for Hepatocellular Carcinoma

AJR Am J Roentgenol. 2021 Oct;217(4):944. doi: 10.2214/AJR.20.25284. Epub 2020 Dec 23.

Author

Thomas B Kinney¹

Affiliation

¹ University of California, San Diego, San Diego, CA tbkinney@ucsd.edu.

PMID: 33355490
DOI: 10.2214/AJR.20.25284

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antibiotics, Antineoplastic
Carcinoma, Hepatocellular* / drug therapy
Carcinoma, Hepatocellular* / therapy
Chemoembolization, Therapeutic* / adverse effects
Doxorubicin
Humans
Liver Neoplasms* / diagnostic imaging
Liver Neoplasms* / drug therapy
Pharmaceutical Preparations*

Substances

Antibiotics, Antineoplastic
Pharmaceutical Preparations
Doxorubicin